Intuitive Surgical (NASDAQ:ISRG) was downgraded by investment analysts at Northland Securities from a “market perform” rating to an “underperform” rating in a note issued to investors on Friday, TheFlyOnTheWall.com reports.
A number of other firms have also recently commented on ISRG. Analysts at Wedbush reiterated an “outperform” rating on shares of Intuitive Surgical in a research note to investors on Tuesday, October 8th. They now have a $495.00 price target on the stock. Separately, analysts at SunTrust upgraded shares of Intuitive Surgical to a “top pick” rating in a research note to investors on Wednesday, September 25th. Finally, analysts at First Analysis downgraded shares of Intuitive Surgical from an “equal weight” rating to an “underweight” rating in a research note to investors on Tuesday, September 3rd. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $492.86.
Shares of Intuitive Surgical (NASDAQ:ISRG) opened at 399.13 on Friday. Intuitive Surgical has a 52-week low of $357.02 and a 52-week high of $585.67. The stock’s 50-day moving average is $379.0 and its 200-day moving average is $440.8. The company has a market cap of $15.849 billion and a P/E ratio of 23.22.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The company reported $3.99 EPS for the quarter, beating the Thomson Reuters consensus estimate of $3.40 by $0.59. The company had revenue of $499.00 million for the quarter, compared to the consensus estimate of $525.47 million. During the same quarter in the prior year, the company posted $4.46 earnings per share. The company’s quarterly revenue was down 7.2% on a year-over-year basis. On average, analysts predict that Intuitive Surgical will post $15.78 earnings per share for the current fiscal year.
Intuitive Surgical, Inc (NASDAQ:ISRG) designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.